D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$484M |
| 2 |
Walt Disney
DIS
|
+$398M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$324M |
| 4 |
GE Aerospace
GE
|
+$187M |
| 5 |
Dell
DELL
|
+$185M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$386M |
| 2 |
PayPal
PYPL
|
+$308M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$278M |
| 4 |
Charter Communications
CHTR
|
+$226M |
| 5 |
Bank of America
BAC
|
+$217M |
Sector Composition
| 1 | Healthcare | 14.49% |
| 2 | Technology | 14.01% |
| 3 | Financials | 12.39% |
| 4 | Consumer Discretionary | 11.96% |
| 5 | Industrials | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEGN
2026
DELISTED
Aegion Corp
AEGN
| $433K | ﹤0.01% |
22,685
+12,125
| +115% | +$231K |
|
2027
Fiserv
FI
$73.9B
| $432K | ﹤0.01% |
+8,690
| New | +$432K |
|
|
DSCI
2028
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $431K | ﹤0.01% |
92,314
-227,005
| -71% | -$1.06M |
|
2029
American Vanguard Corp
AVD
$157M
| $429K | ﹤0.01% |
+26,699
| New | +$429K |
|
2030
Ally Financial
ALLY
$12.8B
| $428K | ﹤0.01% |
21,978
-27,935
| -56% | -$544K |
|
|
CLMS
2031
DELISTED
Calamos Asset Management, Inc.
CLMS
| $426K | ﹤0.01% |
62,423
+14,090
| +29% | +$96.2K |
|
2032
First Interstate BancSystem
FIBK
$3.4B
| $425K | ﹤0.01% |
13,493
-8,517
| -39% | -$268K |
|
2033
Bank of Hawaii
BOH
$2.71B
| $422K | ﹤0.01% |
5,809
-727
| -11% | -$52.8K |
|
2034
City Holding Co
CHCO
$1.83B
| $422K | ﹤0.01% |
8,391
-356
| -4% | -$17.9K |
|
2035
St. Joe Company
JOE
$2.99B
| $422K | ﹤0.01% |
22,973
-25,337
| -52% | -$465K |
|
|
JKS
2036
JinkoSolar
JKS
$1.24B
| $420K | ﹤0.01% |
+26,607
| New | +$420K |
|
2037
New York Times
NYT
$9.51B
| $420K | ﹤0.01% |
35,172
-350,553
| -91% | -$4.19M |
|
2038
Agilysys
AGYS
$3.06B
| $419K | ﹤0.01% |
37,703
-844
| -2% | -$9.38K |
|
2039
Horace Mann Educators
HMN
$1.92B
| $414K | ﹤0.01% |
11,302
-43,210
| -79% | -$1.58M |
|
2040
ORIX
IX
$30.1B
| $414K | ﹤0.01% |
27,935
-43,115
| -61% | -$639K |
|
2041
Inovio Pharmaceuticals
INO
$140M
| $413K | ﹤0.01% |
3,689
-221
| -6% | -$24.7K |
|
|
FCH
2042
DELISTED
Felcor Lodging Trust
FCH
| $412K | ﹤0.01% |
64,171
-65,809
| -51% | -$423K |
|
2043
Zumiez
ZUMZ
$357M
| $410K | ﹤0.01% |
+22,753
| New | +$410K |
|
2044
Trustmark
TRMK
$2.42B
| $409K | ﹤0.01% |
14,844
-62,260
| -81% | -$1.72M |
|
|
CNCE
2045
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $409K | ﹤0.01% |
40,503
+15,692
| +63% | +$158K |
|
|
GMS
2046
DELISTED
GMS Inc
GMS
| $408K | ﹤0.01% |
+18,339
| New | +$408K |
|
|
DTEA
2047
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
| $408K | ﹤0.01% |
+33,096
| New | +$408K |
|
|
MRIN
2048
DELISTED
Marin Software
MRIN
| $407K | ﹤0.01% |
3,844
+890
| +30% | +$94.2K |
|
|
TLN
2049
DELISTED
Talen Energy Corporation
TLN
| $407K | ﹤0.01% |
+29,379
| New | +$407K |
|
2050
Cathay General Bancorp
CATY
$3.41B
| $405K | ﹤0.01% |
13,162
-105,032
| -89% | -$3.23M |
|